Abstract
Purpose
The texture of the pancreatic tissue is a main risk factor for leakage after pancreaticojejunostomy and can be differentiated using dynamic contrast enhanced magnetic resonance imaging (dMRI). In order to identify risk factors and to assess the role of pancreatic dMRI, a cohort of patients was retrospectively reviewed.
Patients and methods
One hundred seven consecutive patients were identified in the departmental database and examined by means of a standardized dMRI protocol using a 1.5-T MRI system. Signal intensity (SI) measurements (aorta, body of the pancreas, muscle tissue) were performed in the axial T1-weighted sequences before and after 25 and 60 s after i.v. application of gadolinium–diethylenetriaminepentaacetic acid. For all patients with a standardized contrast medium curve in the aorta (n = 72), a muscle-normalized signal intensity curve (SIC) with SIratio was calculated. SIratios were classified in two groups: rapid increase (SIratio ≥ 1.1, early arterial value > portal-venous value, “soft” pancreas) and delayed increase (SIratio <1.1, “firm” or “hard” pancreas). All patients received pancreatic head resection with a duct-to-mucosa pancreaticojejunostomy. The dMRI data was correlated with prospectively acquired clinical data.
Results
Leakage of the pancreaticojejunostomy occurred more frequently (12/37 vs. two of 35, 32% vs. 6%, p = 0.006) in patients with a rapid increase and an SIratio ≥ 1.1 (“soft” pancreas, n = 37) compared to those with delayed perfusion (SIratio <1.1, “hard” pancreas, n = 35). The more severe type B and C anastomotic leakages occurred only in the group of patients with SIratio ≥ 1.1. Patients with a rapid increase had significantly better preoperative American Society of Anesthesiologists staging, lower carbohydrate antigen 19-9 values, and smaller tumor sizes. Most of them had not only benign tumors but also longer postoperative hospital stay, in comparison to patients with delayed perfusion (SIratio <1.1). Multivariate analysis revealed SIratio of ≥1.1 to be the only preoperative parameter predicting leakage significantly with an odds ratio of 7.9.
Conclusion
dMRI with SIratio calculation provided reliable information for the prediction of pancreatic texture. Patients with a SIratio ≥ 1.1 had a 7.9-fold increased risk of anastomotic leakage and a prolonged hospital stay. SIC with measurements of SIratio in dMRI could therefore define patients at risk for anastomotic leakage.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
The mortality of pancreatic head resection, with or without pylorus preservation, has significantly declined over the past decades and lies below 5% in experienced centers.1,2 The morbidity of this procedure is, however, high with 301–3 to 60%.4,5 The pancreatic anastomosis is the “Achilles’ heel” in pancreatic surgery.6,7 Leakage of the pancreaticointestinal anastomosis is the main trigger for other morbidities after this procedure. Clinically, a leakage may present as a pancreatic–cutaneous fistula, intraabdominal abscess, delayed gastric emptying, intestinal atony, or it can result in sepsis and hemorrhage leading to a significant mortality.1,7,8 The two common reasons for leakage of pancreatic anastomosis are a “soft” pancreatic texture and a small pancreatic duct size.9–12 Chronic pancreatitis leads to fibrotic, “hard” pancreatic tissue. Anastomotic leakage is therefore observed less frequently after resections due to chronic pancreatitis, compared with resections due to cancer.13 The reported incidence of leakage lies between 0 and 30% and may represent a marked underestimation due to selection bias as well as publication bias.7 Since duct size is an objective parameter the surgeon can easily identify an anastomosis being at risk for leakage during the operation and can spontaneously change the operation procedure; for instance one can decide to switch to another anastomosis technique.
The degree of “softness” of the pancreatic tissue and its role in estimation of an anastomosis being at risk remains to be a problem. Reliable preoperative diagnostic tools or risk scores for prediction of a soft texture are currently not available. The normal exocrine fluid output of the “soft” pancreatic tissue, as compared to that of the fibrotic (“hard”) tissue in patients with chronic pancreatitis, has been described as another risk factor for leakage.7,14 It is therefore not proven that “soft” correlates with “normal” healthy pancreatic tissue. In magnetic resonance imaging (MRI), Sittek and his coauthors could observe various patterns of pancreatic perfusion depending on various pancreatic textures.15
The aim of this study was to evaluate the role of dynamic magnetic resonance imaging (dMRI) in prediction of soft pancreatic texture and leakage of the pancreatic anastomosis. Additionally, it was attempted to identify other risk factors for leakage of the pancreatic anastomosis.
Materials and Methods
Between 2002 and 2007, a total of 217 patients underwent a pancreatic resection (Kausch–Whipple resection or pylorus-preserving pancreaticoduodenectomy) due to a pancreatic head tumor in the Department of Surgery. All patients were identified in the prospective departmental pancreatic database.1,16–18 During this 5-year period, a total number of 107 consecutive patients with a sonographically suspected tumor of the pancreas head were evaluated by dMRI prior to resection. All patients with a dMRI in our institution were included in the present analysis. The data of the latter patients examined comprised demographics; pathology report; tumor, node, metastasis stage; and International Union Against Cancer classification, preoperative presenting symptoms, preoperative procedures (e.g., biliary stent), lab work (including tumor marker carbohydrate antigen (CA) 19-9), the American Society of Anesthesiologists (ASA) score, details of the surgical therapy (including blood loss and blood transfusions), the hospital course (including complications), and the postoperative survival.
Follow-up was performed through personal contact with the patient or patient’s primary physician and was terminated on June 1 2008 or at patient’s death. All deaths occurring within 30 days after surgery or throughout the hospital stay were classified as surgical mortality. In all patients, drains were placed at the pancreaticojejunostomy and at the hepaticojejunostomy site.
An anastomotic leakage was defined according to the International Study Group on Pancreatic Fistula (ISGPF) definition.19 A grade A leakage is a so-called “biochemical, transient fistula” and has no clinical impact. A grade A leakage requires little change in management or deviation from the normal clinical pathway. A grade B leakage requires a change in the patient management or an adjustment in the clinical pathway. It usually leads to a delay in discharge, to readmission, or to discharge of the patient with drains in situ. A grade C leakage leads to a major change in the clinical management or a deviation from the normal clinical pathway. A deteriorating clinical status with a grade C leakage together with sepsis and an organ dysfunction may require reexploration in an attempt to repair the site of leakage with wide peripancreatic drainage, or a conversion to alternative pancreaticoenteric anastomosis, or a complete pancreatectomy.
Surgical Technique of Pancreatic Anastomosis
Within 1 to 10 days (median 3 days) after the dMRI, all patients underwent a pancreatic head resection (Kausch–Whipple or pylorus-preserving procedure) with reconstruction as duct-to-mucosa pancreaticojejunostomy. The two-layer pancreatointestinal anastomosis was standardized as follows: After mobilization of the pancreatic remnant, the inner suture layer was placed on the pancreatic duct. Usually eight stitches were required (resorbable monofilament 5-0 sutures), the posterior wall was sutured from inside to outside, the anterior wall from outside to inside. The mesenteric surface of jejunum was approximated to the pancreas stump. The posterior wall of the outer suture layer was sewn in a running manner after placing a knot on the cranial edge of the pancreas (resorbable monofilament 4-0 sutures). A small incision corresponding to the localization and diameter of the pancreatic duct was made on the antimesenteric surface of the jejunum and the inner layer (duct to mucosa) was completed by stitching the previously placed sutures and tying them gently. The anastomosis was completed by a running suture of the outer anterior wall with the previously placed suture (serosal surface of the pancreatic remnant to seromuscular layer of jejunum; Fig. 1). Two soft drains were placed in every patient: one at the pancreatic anastomosis and one close to the hepaticojejunostomy.
Dynamic MRI
All patients underwent a MRI examination of the pancreas using the same 1.5-T system (Magnetom Vision, Siemens Medical Solutions, Erlangen, Germany). The sequence protocol is described in Table 1 in detail. All patients underwent standard sequences for the description of the morphology followed by a native T1-weighted fat saturated sequence centered on the body of the pancreas with a slice thickness of 5 mm without a gap. The sequence was repeated after intravenous administration of 0.1 mmol/kg bodyweight gadolinium–diethylenetriaminepentaacetic acid (Gd-DTPA; Magnevist®, Bayer Schering, Berlin, Germany) via an automatized injection with a flow rate of 2 ml/s using a 21-G i.v. line in a cubital vein, followed by a saline flush with 40 ml isotonic saline solution. The T1-weighted fat saturated sequence was repeated approximately 25 and 60 s after application of contrast medium in the axial plane, after 2 min in a coronal plane, and after 2.5 min for the termination of the examination in an axial plane without fat saturation. In order to compare pancreas-healthy individuals with the resected patients, the MRI data of 15 age- and gender-correlated patients without an apparent pancreatic or liver disease were evaluated within 12 months after the dMRI examination following the above mentioned protocol.
dMRI Image Evaluation
A measurement of the signal intensity (SI) was carried out in different regions of interests (RoIs) with at least 16 pixels for reliable results. The first RoI was measured in the pancreatic tissue at the estimated resection line, with and without the pancreatic duct. Further, RoIs were inside the aorta at the axial plane of the pancreas body and inside the paravertebral muscle (spinal erector muscle) for the normalization of the measurements (Fig. 2a–d). In the initial evaluation, all patients with a nondiagnostic contrast media application (all patients with an increase of the SI in the aorta after the initial arterial peak) were excluded. The measurement results in the pancreas were normalized by setting the increase in the pancreas in relation to the increase in the muscle according to the formulas described in Table 2.
The patients were classified into two groups according the pattern of perfusion following the ratio: \({\text{SI}}_{{\text{ratio}}} {\text{ = }}\left( {\frac{{{\text{SI}}_{{\text{ea}}} }}{{{\text{SI}}_{{\text{pv}}} }}} \right)\). SIea was defined as the signal intensity in the early arterial phase and SIpv as the portal-venous phase after the application of contrast. If the pancreatic tissue demonstrated a muscle-normalized SIratio of ≥1.1, the patients were assigned to group 1 (normal perfusion of the organ). Patients who demonstrated an SIratio <1.1 were assigned to group 2 (decreased perfusion of the organ). An age-matched group of 15 volunteers without history of a pancreatic disease were evaluated using the same examination and evaluation protocol.
Statistical Analyses
The primary endpoint of the study was the leakage of the pancreatic anastomosis. A Fisher’s exact test was performed comparing the two groups. A chi-square test was performed comparing various patient data and the perfusion values. A multivariate analysis (logistic regression) was calculated with an odds ratio (OR) for all parameters described. Predicting factors for the leakage were examined by univariate and multivariate analyses, using Cox’s proportional hazards including a calculation of the odds ratio for all parameters described. Significance was accepted at the probability level of 0.05. All statistical calculations were performed using the SAS software (release 9.01; SAS Institute Inc., Cary, NC, USA).
Results
All examinations were performed with the same sequence protocol without any study violation. A total of 107 patients (median age 67.5 years, range 30–89 years, 65 men, 42 women) were included in the evaluation. In 72 patients (median age 67 years, range 30–89 years, 42 men, 30 women), the early arterial SI in the aorta was higher than the portal venous SI, showing the correct timing of the contrast media application. These 72 patients fulfilled criteria for the further examination (Table 3).
Perioperative Course
An uncomplicated postoperative course was observed in 31% of all patients (22/72). The overall morbidity rate was 69% (50/72); the postoperative mortality was 1.4% (one of 72). A classic Kausch–Whipple resection was performed in 27 patients (37.5%), a preservation of the pylorus-preserving pancreatoduodenectomy (PPPD) could be achieved in 45 patients (62.5%). Leakage of the pancreaticojejunostomy was observed in 14 patients (19.4%): grade A leakage in nine patients, grade B leakage in three, and grade C leakage requiring relaparotomy in two patients. In one of the latter patients, the anastomosis was converted; in the other patient, a complete pancreatectomy was necessary. This patient died subsequently on the 24th postoperative day. A leakage of the hepaticojejunostomy occurred in four patients (5.5%; Table 4). Seven (9.7%) patients required relaparotomy for complications, postoperative bleeding occurred in three (4.2%) patients, nine (12.5%) patients developed a delayed gastric emptying, and five (6.9%) patients presented with an intraabdominal abscess (Table 4).
Histopathology revealed cancer in 54 patients (75%): 33 ductal adenocarcinoma, five distal bile duct carcinoma, five carcinoma of Vater’s papilla, 11 miscellaneous malignant tumors. Nine (12.5%) patients were diagnosed with a chronic pancreatitis, and nine (12.5%) patients had a benign lesion (for example noninvasive intraductal papillary mucinous neoplasm).
Evaluation of dMRI and Correlation with Clinical Parameters
Thirty-seven of the 72 patients who qualified for the final analysis (median age 67 years, range 30–89 years, 21 men, 16 women) revealed a pancreatic perfusion with an SIratio ≥1.1. Thirty-five patients (median age 68 years, range 40–85 years, 21 men, 14 women) had an SIratio <1.1. All pancreas-healthy patients in the control group showed an SIratio ≥ 1.1. An SIratio ≥ 1.1 was therefore equivalent to a “normal” pancreatic perfusion.
A comparison of the perfusion in dMRI and the clinical parameters revealed the following statistically significant results. In comparison to patients with a delayed perfusion (SIratio <1.1), those with a “normal” perfusion (SIratio ≥1.1) were significantly more often classified as ASA group I/II (no or mild comorbidities, p = 0.004). These patients had lower preoperative CA 19-9 levels (22 vs. 152 U/l, p = 0.01) and a smaller tumor size (23 vs. 32 mm, p = 0.007).
Regarding the postoperative results, patients with a normal perfusion (SIratio ≥ 1.1) had statistically significant higher rate of leakage of the pancreaticojejunostomy (p = 0.006); 12 of 14 leakages (86%) occurred in patients with a normal perfusion (SIratio ≥ 1.1) compared to only two of 14 leakages in patients with a delayed (SIratio <1.1) perfusion. All grade B and C leakages occurred in patients with a normal perfusion. Two of 12 patients required relaparotomy (grade C) and three patients were discharged with drains in place, or needed a reintervention (grade B). In contrast to these findings, only in two patients with an signal intensity curve (SIC) <1.1 that a “biochemical” leakage (grade A) occurred. Patients with a normal perfusion had a significantly longer hospital stay (20 vs. 17 postoperative days, p = 0.05) and were more likely to have other postoperative complications, resulting in an overall morbidity rate of 78% (29/37 vs. 21/35). This difference, however, was of no statistical significance (p = 0.07; Table 4).
In order to reveal predictive factors of an anastomotic leakage, all preoperative parameters were evaluated in a multivariate analysis. The SIratio ≥ 1.1 was shown to be the only parameter with a strong statistically significant correlation with the postoperative leakage (p = 0.0042, odds ratio (OR) 7.92). All other parameters, such as ASA score, chronic pancreatitis, pancreatic cancer, tumor size, diabetes, etc., revealed no significant correlation (Table 3). The perfusion pattern in dMRI was therefore the only preoperative parameter predicting the probability of having a postoperative leakage (OR 7.92). The risk of developing a leakage was 7.9-folds higher in patients with a normal pancreatic perfusion and an SIratio ≥ 1.1 in dMRI, in comparison to those with an SIratio <1.1 in dMRI (Table 5).
Discussion
One of the challenges following a pancreaticointestinal reconstruction is the prevention of an anastomotic leakage. A leakage is a critical factor influencing postoperative morbidity and mortality.7,20,21 As a result, over 70 different techniques for reconstruction of the pancreatic remnant following pancreatic head resection have been described.7 The multitude of the suggested modifications, however, reflects that none of the techniques is perfect enough to convince every pancreatic surgeon for every intraoperative situation (“soft” or “firm” gland). Furthermore, there are no objective criteria to assess the texture of the pancreas prior to the operation, in order to adapt the surgical technique adequately and to inform the patients at risk for anastomotic leakage. The texture of the pancreatic tissue is explained by its pathophysiology. The natural texture is “soft” with a main pancreatic duct of a maximum diameter of 3 mm. The perfusion of this type of gland is not impaired. Following a chronic pancreatitis, the gland is usually fibrotic and firm with an impaired perfusion.14 Other pancreatic disorders such as solid or cystic pancreatic tumors can lead to a variety of texture changes from “soft” to firm” along with different perfusion pattern.22–24 Various pancreatic perfusion behavior in dMRI correlates with changes of the pancreatic texture.15 Pancreatic perfusion in dMRI, calculated as SIC by measuring the SIratio was therefore studied as a predictor for an anastomotic failure. It was examined as a possible objective measure for the assessment of the texture of the pancreatic remnant.
dMRI Pancreatic Imaging
The main protocol in 1.5-T MRI consists of a standard evaluation with T2-weighted (turbo-) spin echo sequences and diffusion-weighted images of the upper abdomen, with a calculation of the resulting apparent diffusion coefficients. The magnetic resonance cholangiopancreaticography is performed by fast T2-weighted images in half-Fourier acquired T2-weighted single-shot turbo spin-echo sequences technique and rapid acquisition with relaxation enhancement technique. The native protocol is completed by T1-weighted images, with and without fat saturation for the delineation of the pancreas tissue. These sequences are followed by application of an MR contrast media, usually Gd-DTPA, in order to describe the contrast kinetics of tumors in terms of them being hypo-, iso-, or hyperintense after contrast media application. The examination is terminated by repeating the T1-weighted sequences in axial and coronal planes.25 The examination can be performed with an axial thin-sliced T1-weighted sequence with fat saturation in order to visualize the pancreas in the early arterial, as well as in the portal-venous phase with excellent delineation of the tissue. The limitations, however, are in the exact description of vessel involvement, in case of an abnormal localization of the pancreas tissue, or of the upper abdominal vessels.25–28 Another examination mode is the use of a coronal three-dimensional (3D) sequences as an angiographic examination, usually as a 3D volume interpolated breath-hold examination sequence. The advantage of this sequence is the high resolution with a voxel size of 1 mm3. The disadvantage, however, is the sequence inherent signal-to-noise ratio, leading to a decrease in the quality of the evaluation of the pancreatic tissue. The results of the described techniques are, nevertheless, encouraging, and both methods are used in the imaging technique of the pancreas.25,26 The protocol used in this study consisted of the described thin slice axial T1-weighted sequence with the advantage of integrating delineation of morphology and the dynamic contrast enhancement aspect.
Exact imaging is essential for the exact differentiation of the tumor, the vessel infiltration of the arterial and venous vessels, and for staging of possible metastases.25,29,30 Only a small number of previous investigators, however, have assessed pancreatic perfusion by performing a semiquantitative analysis of gadolinium enhancement parameters.31–33 The quantitative analysis of regional blood perfusion using dMRI has been described for different tissues.31–33 Although the study of Bali et al.34 proposed an approach to quantify parameters with a so-called “one compartment model” for the pancreatic parenchyma, there is currently no standard of reference available for the perfusion parameters of the pancreas. Using semiquantitative methods, Coenegrachts and coworkers described a statistically significant difference between patients with chronic pancreatitis and healthy volunteers in the so-called “wash in time” as well as in the “time to inflow deceleration”. They demonstrated a better contrast media enhancement in healthy volunteers in all parts of the pancreas.31 Other studies from Tajima and his coworkers32,33 applied the so-called “time intensity curves”. This parameter was calculated as a function of signal intensity (SI post − SI pre)/SI pre × 100%) and lead to a differentiation between two various tissue types: those with a good perfusion (rapid rise to a peak in the early arterial phase followed by a rapid decline) and those with a restricted perfusion (slow rise to a peak beginning at the portal-venous phase followed by a slow decline or very slow rise to a late peak followed by a decline or a plateau). These groups could be differentiated using different contrast media behavior 25 and 60 s after contrast media application. Similar to the present study the study of Tajima and his coworkers was aimed to predict possible anastomotic leakage. Their study, however, had major limitations concerning the reliability. The authors did not mention the measurement of the pancreatic duct, which was obviously inside the RoI. This leads to false measurements, since the content of the duct, which is water like, shows no contrast media enhancement, resulting in reduced signal intensity. Furthermore, the authors did not consider the different normalization levels of the images, or the different circulation times of the patients. These issues alter the signal intensity curves as well. As a significant modification, the present study included only patients who had an increase of the signal intensity in the aorta in the first arterial phase and revealed a decrease of the values in the second measurement. In the current study, only the tissue and not the duct was measured. This led to RoI which included only 6 to 8 pixels in some patients. The measurement was therefore more reliable than measuring the duct. Furthermore, the signal intensities were normalized in every patient with a very slow enhancing muscle tissue, in order to obtain more intra- as well as interindividually comparable measurements. The image-inherent noise level was also taken into consideration.35
Prediction of Anastomotic Leakage
In this series of 72 pancreatic head resections, 14 patients (19.4%) developed a leakage (nine grade A, three grade B, two grade C) postoperatively. This was a reasonable value compared to 1,507 patients of a multicenter database having a leakage rate of 26.7% according to the ISGPF definition.9 In this study, the less severe type of leakage (grade A) occurred more frequently (64% vs. 48%). As a main result, it could be demonstrated that patients with a normal perfusion (SIratio ≥ 1.1) had significantly higher rate of leakage (p = 0.006) and a higher rate of more severe leakage types. All grade B and C leakages occurred in patients with SIratio ≥ 1.1. Consecutively, patients with a normal perfusion (SIratio ≥ 1.1) had a significantly longer hospital stay (p = 0.05) and were more likely to have other postoperative complications (p = 0.07). In a multivariate analysis, it could be shown that the SIratio ≥ 1.1 was the only parameter revealing a strong statistically significant correlation with postoperative leakage (p = 0.0042) with an odds ratio of 7.92. This implies that the risk of anastomotic failure in patients with a normal pancreatic perfusion is 7.92-folds higher than those with an impaired perfusion. The cutoff value for the SI ratio was chosen as a consequence of, and an improvement to the studies by Tajima,32,33 who did not include the normalization of the values according to the muscle tissue.
Type of Resection
A recent meta-analysis36 demonstrated no differences between the types of anastomosis (pancreatojejunostomy or pancreatogastrostomy) regarding gastric emptying time, pancreatic exocrine or endocrine insufficiency, or findings of ulcerative disorders in the endoscopy. The rate of pancreatic remnant related relaparotomies was, however, higher in the group of the patients who underwent pancreatojejunostomy.37,38 Although in the present study pancreaticojejunostomy using a duct-to-mucosa technique was performed in all cases, there was a rate of 14/72 anastomotic leakages. Other groups such as Hayashibe and coauthors39 described a series of 55 consecutive patients without a pancreatic anastomotic leakage after duct-to-mucosa anastomosis in all cases. The cited group considered this kind of anastomosis to be safe, having low complication rates, being reliable and favorable for the anastomosis after pancreatoduodenectomy. The findings of this study are in accordance with the leakage rate described in the literature,40–42 which lies between 5% and 25% in patients after pancreaticojejunostomy.
Prediction of a Soft Pancreas
As a main result, a strong correlation was found between an SIratio ≥ 1.1 and a pancreas parenchyma of age-correlated healthy volunteers showing the same contrast enhancement. A similar finding has been described by Tajima et al.,32 who described the perfusion of the pancreas to be the only independent variable for the prediction of leakage. As mentioned above, this was, however, performed with a technique which was less elaborate and reliable than the one in the present study. Patients with pancreas tumors addressed to have a resection of the pancreatic head can be categorized into two groups: (1) patients with a soft, fragile pancreas, and/or small pancreatic duct and (2) those with a fibrotic, firm pancreas, and/or dilated pancreatic duct. The first group is described to have a high risk for postoperative pancreatic anastomotic leakage, the second group to have a lower risk.23,43,44 In the present study, there were better preoperative conditions described, along with an “objective” classification such as ASA classification, in the group with a better perfusion, which revealed a higher rate of anastomotic failure. This could lead to the assumption that objectively healthier patient are at a higher risk for anastomotic complications, due to a well-perfused soft gland. There is therefore a necessity for having other therapeutic options for patients at risk for a leakage. The change of the anastomotic technique in these patients (for instance from pancreaticojejunostomy to pancreatogastrostomy) could be a possible option (Fig. 3).
In summary, the present study demonstrated in particular a high rate of anastomotic leakage in patients with a regular perfusion of the pancreas parenchyma. This was contradictory to the fact that these patients had a lower surgical risk in general. Using a simple method of relative perfusion quantification, based on the contrast media enhancement of the pancreas in relation to the aorta and the muscle tissue, it is possible to identify patients at risk for postoperative anastomotic leakage. Through applying the described dMRI technique, pancreatic surgeons can therefore preoperatively inform patients about their risk and possibly stratify these patients for other anastomotic techniques in the future.
References
Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 2003;27(3):324–329. doi:10.1007/s00268-002-6659-z.
Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 1990;211(4):447–458. doi:10.1097/00000658-199004000-00011.
Trede M, Schwall G. The complications of pancreatectomy. Ann Surg 1988;207(1):39–47. doi:10.1097/00000658-198801000-00009.
Adam U, Makowiec F, Riediger H, Schareck WD, Benz S, Hopt UT. Risk factors for complications after pancreatic head resection. Am J Surg 2004;187(2):201–208. doi:10.1016/j.amjsurg.2003.11.004.
DeOliveira ML, Winter JM, Schafer M, Cunningham SC, Cameron JL, Yeo CJ, et al. Assessment of complications after pancreatic surgery: a novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg 2006;244(6):931–937. doi:10.1097/01.sla.0000246856.03918.9a, discussion 937–939.
Callery MP, Pratt WB, Vollmer CM Jr. Prevention and management of pancreatic fistula. J Gastrointest Surg 2008 (in press).
Niedergethmann M, Farag Soliman M, Post S. Postoperative complications of pancreatic cancer surgery. Minerva Chir 2004;59(2):175–183.
Strasberg SM, Linehan DC, Clavien PA, Barkun JS. Proposal for definition and severity grading of pancreatic anastomosis failure and pancreatic occlusion failure. Surgery 2007;141(4):420–426. doi:10.1016/j.surg.2006.12.001.
Reid-Lombardo KM, Farnell MB, Crippa S, Barnett M, Maupin G, Bassi C, et al. Pancreatic anastomotic leakage after pancreaticoduodenectomy in 1,507 patients: a report from the Pancreatic Anastomotic Leak Study Group. J Gastrointest Surg 2007;11(11):1451–1458. doi:10.1007/s11605-007-0270-4, discussion 1459.
Shinchi H, Wada K, Traverso LW. The usefulness of drain data to identify a clinically relevant pancreatic anastomotic leak after pancreaticoduodenectomy? J Gastrointest Surg 2006;10(4):490–498. doi:10.1016/j.gassur.2005.08.029.
Traverso LW. Pancreatic cancer: surgery alone is not sufficient. Surg Endosc 2006;20(Suppl 2):S446–449. doi:10.1007/s00464-006-0052-1.
Yang YM, Tian XD, Zhuang Y, Wang WM, Wan YL, Huang YT. Risk factors of pancreatic leakage after pancreaticoduodenectomy. World J Gastroenterol 2005;11(16):2456–2461.
Bartoli FG, Arnone GB, Ravera G, Bachi V. Pancreatic fistula and relative mortality in malignant disease after pancreaticoduodenectomy. Review and statistical meta-analysis regarding 15 years of literature. Anticancer Res 1991;11(5):1831–1848.
Murakami H, Suzuki H, Nakamura T. Pancreatic fibrosis correlates with delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy with pancreaticogastrostomy. Ann Surg 2002;235(2):240–245. doi:10.1097/00000658-200202000-00012.
Sittek H, Heuck AF, Folsing C, Gieseke J, Reiser M. Static and dynamic MR tomography of the pancreas: contrast media kinetics of the normal pancreatic parenchyma in pancreatic carcinoma and chronic pancreatitis. Rofo 1995;162(5):396–403.
Hartel M, Niedergethmann M, Farag-Soliman M, Sturm JW, Richter A, Trede M, et al. Benefit of venous resection for ductal adenocarcinoma of the pancreatic head. Eur J Surg 2002;168(12):707–712. doi:10.1080/00000000000000007.
Niedergethmann M, Richter A, Wendl K, Schmidt B, Post S, Trede M. Rare indications for a Kausch–Whipple procedure. Eur J Surg 2001;167(2):115–119. doi:10.1080/110241501750070565.
Niedergethmann M, Shang E, Farag Soliman M, Saar J, Berisha S, Willeke F, et al. Early and enduring nutritional and functional results of pylorus preservation vs classic Whipple procedure for pancreatic cancer. Langenbecks Arch Surg 2006;391(3):195–202. doi:10.1007/s00423-005-0015-3.
Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005;138(1):8–13. doi:10.1016/j.surg.2005.05.001.
Bassi C, Butturini G, Molinari E, Mascetta G, Salvia R, Falconi M, et al. Pancreatic fistula rate after pancreatic resection. The importance of definitions. Dig Surg 2004;21(1):54–59. doi:10.1159/000075943.
Yeo CJ. Management of complications following pancreaticoduodenectomy. Surg Clin North Am 1995;75(5):913–924.
de Castro SM, Kuhlmann KF, Busch OR, van Delden OM, Lameris JS, van Gulik TM, et al. Incidence and management of biliary leakage after hepaticojejunostomy. J Gastrointest Surg 2005;9(8):1163–1171. doi:10.1016/j.gassur.2005.08.010, discussion 1171–1163.
Lin JW, Cameron JL, Yeo CJ, Riall TS, Lillemoe KD. Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula. J Gastrointest Surg 2004;8(8):951–959. doi:10.1016/j.gassur.2004.09.044.
van Berge Henegouwen MI, De Wit LT, Van Gulik TM, Obertop H, Gouma DJ. Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant. J Am Coll Surg 1997;185(1):18–24.
Schima W, Ba-Ssalamah A, Goetzinger P, Scharitzer M, Koelblinger C. State-of-the-art magnetic resonance imaging of pancreatic cancer. Top Magn Reson Imaging 2007;18(6):421–429. doi:10.1097/rmr.0b013e31816459e0.
Gaa J, Wendl K, Tesdal IK, Meier-Willersen HJ, Lehmann KJ, Bohm C, et al. Combined use of MRI and MR cholangiopancreatography and contrast enhanced dual phase 3-D MR angiography in diagnosis of pancreatic tumors: initial clinical results. Rofo 1999;170(6):528–533.
Sahani DV, Shah ZK, Catalano OA, Boland GW, Brugge WR. Radiology of pancreatic adenocarcinoma: current status of imaging. J Gastroenterol Hepatol 2008;23(1):23–33.
Zhong L. Magnetic resonance imaging in the detection of pancreatic neoplasms. J Dig Dis 2007;8(3):128–132. doi:10.1111/j.1443-9573.2007.00297.x.
Schima W. MRI of the pancreas: tumours and tumour-simulating processes. Cancer Imaging 2006;6:199–203. doi:10.1102/1470-7330.2006.0035.
Trede M, Rumstadt B, Wendl K, Gaa J, Tesdal K, Lehmann KJ, et al. Ultrafast magnetic resonance imaging improves the staging of pancreatic tumors. Ann Surg 1997;226(4):393–405. doi:10.1097/00000658-199710000-00001, discussion 405–397.
Coenegrachts K, Van Steenbergen W, De Keyzer F, Vanbeckevoort D, Bielen D, Chen F, et al. Dynamic contrast-enhanced MRI of the pancreas: initial results in healthy volunteers and patients with chronic pancreatitis. J Magn Reson Imaging 2004;20(6):990–997. doi:10.1002/jmri.20212.
Tajima Y, Kuroki T, Tsutsumi R, Fukuda K, Kitasato A, Adachi T, et al. Risk factors for pancreatic anastomotic leakage: the significance of preoperative dynamic magnetic resonance imaging of the pancreas as a predictor of leakage. J Am Coll Surg 2006;202(5):723–731. doi:10.1016/j.jamcollsurg.2006.01.008.
Tajima Y, Matsuzaki S, Furui J, Isomoto I, Hayashi K, Kanematsu T. Use of the time-signal intensity curve from dynamic magnetic resonance imaging to evaluate remnant pancreatic fibrosis after pancreaticojejunostomy in patients undergoing pancreaticoduodenectomy. Br J Surg 2004;91(5):595–600. doi:10.1002/bjs.4461.
Bali MA, Metens T, Denolin V, De Maertelaer V, Deviere J, Matos C. Pancreatic perfusion: noninvasive quantitative assessment with dynamic contrast-enhanced MR imaging without and with secretin stimulation in healthy volunteers—initial results. Radiology 2008;247(1):115–121.
Noworolski SM, Henry RG, Vigneron DB, Kurhanewicz J. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med 2005;53(2):249–255. doi:10.1002/mrm.20374.
Wente MN, Shrikhande SV, Muller MW, Diener MK, Seiler CM, Friess H, et al. Pancreaticojejunostomy versus pancreaticogastrostomy: systematic review and meta-analysis. Am J Surg 2007;193(2):171–183. doi:10.1016/j.amjsurg.2006.10.010.
Aranha GV, Hodul P, Golts E, Oh D, Pickleman J, Creech S. A comparison of pancreaticogastrostomy and pancreaticojejunostomy following pancreaticoduodenectomy. J Gastrointest Surg 2003;7(5):672–682. doi:10.1016/S1091-255X(02)00432-8.
Fang WL, Su CH, Shyr YM, Chen TH, Lee RC, Tai LC, et al. Functional and morphological changes in pancreatic remnant after pancreaticoduodenectomy. Pancreas 2007;35(4):361–365.
Hayashibe A, Kameyama M. The clinical results of duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy in consecutive 55 cases. Pancreas 2007;35(3):273–275.
Cameron JL, Pitt HA, Yeo CJ, Lillemoe KD, Kaufman HS, Coleman J. One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg 1993;217(5):430–435. doi:10.1097/00000658-199305010-00002,, discussion 435–438.
Gouma DJ, van Geenen RC, van Gulik TM, de Haan RJ, de Wit LT, Busch OR, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg 2000;232(6):786–795. doi:10.1097/00000658-200012000-00007.
Yeo CJ, Cameron JL, Lillemoe KD, Sauter PK, Coleman J, Sohn TA, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg 2000;232(3):419–429. doi:10.1097/00000658-200009000-00014.
Fujino Y, Suzuki Y, Ajiki T, Tanioka Y, Ku Y, Kuroda Y. Risk factors influencing pancreatic leakage and the mortality after pancreaticoduodenectomy in a medium-volume hospital. Hepatogastroenterology 2002;49(46):1124–1129.
Hosotani R, Doi R, Imamura M. Duct-to-mucosa pancreaticojejunostomy reduces the risk of pancreatic leakage after pancreatoduodenectomy. World J Surg 2002;26(1):99–104. doi:10.1007/s00268-001-0188-z.
Author information
Authors and Affiliations
Corresponding author
Additional information
Dietmar J. Dinter and Niloufar Aramin contributed equally to this work.
Rights and permissions
About this article
Cite this article
Dinter, D.J., Aramin, N., Weiss, C. et al. Prediction of Anastomotic Leakage After Pancreatic Head Resections by Dynamic Magnetic Resonance Imaging (dMRI). J Gastrointest Surg 13, 735–744 (2009). https://doi.org/10.1007/s11605-008-0765-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-008-0765-7